These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28561046)

  • 1. Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.
    Dunne PD; Alderdice M; O'Reilly PG; Roddy AC; McCorry AMB; Richman S; Maughan T; McDade SS; Johnston PG; Longley DB; Kay E; McArt DG; Lawler M
    Nat Commun; 2017 May; 8():15657. PubMed ID: 28561046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer.
    Dunne PD; McArt DG; Bradley CA; O'Reilly PG; Barrett HL; Cummins R; O'Grady T; Arthur K; Loughrey MB; Allen WL; McDade SS; Waugh DJ; Hamilton PW; Longley DB; Kay EW; Johnston PG; Lawler M; Salto-Tellez M; Van Schaeybroeck S
    Clin Cancer Res; 2016 Aug; 22(16):4095-104. PubMed ID: 27151745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
    J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.
    Han J; Rong LF; Shi CB; Dong XG; Wang J; Wang BL; Wen H; He ZY
    World J Gastroenterol; 2014 Jul; 20(25):8139-50. PubMed ID: 25009386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer.
    Wang X; Li T
    Bioengineered; 2020 Dec; 11(1):165-174. PubMed ID: 32036725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
    Vellinga TT; Kranenburg O; Frenkel N; Ubink I; Marvin D; Govaert K; van Schelven S; Hagendoorn J; Borel Rinkes IH
    Ann Surg; 2017 Nov; 266(5):765-771. PubMed ID: 28742689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
    Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
    PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
    Cheng J; Guo Y; Guan G; Huang H; Jiang F; He J; Wu J; Guo Z; Liu X; Ao L
    J Cell Mol Med; 2021 Apr; 25(7):3622-3633. PubMed ID: 33719152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
    Wang S; Zhou J; Wang XY; Hao JM; Chen JZ; Zhang XM; Jin H; Liu L; Zhang YF; Liu J; Ding YQ; Li JM
    J Pathol; 2009 Sep; 219(1):114-22. PubMed ID: 19557828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and optimization of gene expression signatures for prediction of survival in two-arm clinical trials.
    Theilhaber J; Chiron M; Dreymann J; Bergstrom D; Pollard J
    BMC Bioinformatics; 2020 Jul; 21(1):333. PubMed ID: 32711453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in stromal signatures in breast and colorectal cancer metastases.
    Webster JA; Beck AH; Sharma M; Espinosa I; Weigelt B; Schreuder M; Montgomery KD; Jensen KC; van de Rijn M; West R
    J Pathol; 2010 Oct; 222(2):158-65. PubMed ID: 20593409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma.
    Luo S; Jia Y; Zhang Y; Zhang X
    JHEP Rep; 2023 Jun; 5(6):100754. PubMed ID: 37234275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
    Daemen A; Udyavar AR; Sandmann T; Li C; Bosch LJW; O'Gorman W; Li Y; Au-Yeung A; Takahashi C; Kabbarah O; Bourgon R; Hegde P; Bais C; Das Thakur M
    PLoS One; 2021; 16(12):e0262198. PubMed ID: 34972191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing a novel and robust technique for determining lymph node status in colorectal cancer.
    Hogan J; Judge C; O'Callaghan M; Aziz A; O'Connor C; Burke J; Dunne C; Walsh S; Kalady M; Coffey JC
    Ann Surg; 2014 Jul; 260(1):94-102. PubMed ID: 24169164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
    Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
    Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.